Scientists in the US and China have provided tantalising evidence of the potential for an eye drop treatment for cataracts, which could advance to clinical trials in as little as a year.
The research, published in the journal Nature, shows that treating cataractous lenses with lanosterol, a molecular building block of steroids, was found to reduce the cloudy protein build up in the tissue. The findings identify the molecule as a key component in cataract formation and highlight its potential as a non-surgical treatment.
Read more at http://www.optometry.co.uk/news-and-.../?article=7562
Bookmarks